Brief: Scope Fluidics Updates Objectives For Bacteromic Project For 2026-2027

Scope Fluidics SA

09/03/2026 16:15

March 9 (Reuters) - Scope Fluidics SA SCPP.WA:

UPDATES OBJECTIVES FOR BACTEROMIC PROJECT FOR 2026-2027

ANALYZING NEEDS OF AST END USERS LED BACTEROMIC TEAM TO FOCUS ON DEVELOPMENT, CERTIFICATION, AND COMMERCIALIZATION OF PANELS COMPATIBLE WITH FAST DETECTION SOFTWARE

RESEARCH AND DEVELOPMENT WORK WILL BE CONDUCTED ON PANELS: UNI FAST, EXTENDED UNI FAST PANEL AND PBC

PLANS TO OBTAIN CE-IVDR CERTIFICATION FOR UNI FAST PANEL IN MID-2026

FDA CERTIFICATION FOR EXPANDED VERSION OF UNI FAST PANEL IS PLANNED FOR MID-2027

EXPECTS CE-IVDR CERTIFICATION FOR PBC PANEL BY END OF 2027

DOES NOT FORESEE FDA CERTIFICATION FOR PBC PANEL BY END OF 2027

EXPECTS FIRST REVENUES FROM BACTEROMIC SYSTEM SALES IN 2026

IMPLEMENTATION OF 2026-2027 GOALS SHOULD NOT REQUIRE OBTAINING ADDITIONAL FUNDING

MANAGEMENT DECIDED TO DISCONTINUE ACTIVITIES AIMED AT SIGNING DEALS WITH EUROPEAN INVESTMENT BANK REGARDING UP TO EUR 15 MILLION FINANCING FOR BACTEROMIC PROJECT

Source text: ID:nEMcgFXfba

Further company coverage: SCPP.WA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))